JAGSON PHAR share price has plunged 5% and is presently trading at Rs 375.6.
Meanwhile, the BSE HEALTHCARE index is at 41,148.2 (up 0.8%).
Among the top losers in the BSE HEALTHCARE index today are DR. LAL PATHLABS (down 1.8%) and FDC (down 1.5%).
Abbott India (up 3.5%) and ALEMBIC PHARMA (up 3.2%) are among the top gainers today.
Over the last one year, JAGSON PHAR has moved down from Rs 439.9 to Rs 375.6, registering a loss of Rs 64.4 (down 14.6%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 41,148.2, registering a gain of 45.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 116.8%), GSK Pharma (up 107.8%) and SUVEN PHARMACEUTICALS (up 105.8%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,177.5 (down 0.4%).
The top losers among the BSE Sensex today are Infosys (down 2.2%) and Asian Paints (down 2.1%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,197.2 (down 0.4%). BPCL and Infosys are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 79,177.5, registering a gain of 13,224.0 points (up 20.1%).
JAGSON PHAR net profit fell 28.7% YoY to Rs 53 million for the quarter ended June 2024, compared to a profit of Rs 75 million a year ago. Net sales rose 2.1% to Rs 614 million during the period as against Rs 602 million in April-June 2023.
For the year ended March 2023, JAGSON PHAR reported 41.7% increase in net profit to Rs 267 million compared to net profit of Rs 189 million during FY22. Revenue of the company grew 8.8% to Rs 2,367 million during FY23.
The current Price to earnings ratio of JAGSON PHAR, based on rolling 12 month earnings, stands at 48.9.
Equitymaster requests your view! Post a comment on "JAGSON PHAR Plunges 5%; BSE HEALTHCARE Index Up 0.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!